How AI can make drug discovery fail less, with Daphne Koller from Insitro
Life-saving therapeutics continue to grow more costly to discover. At the same time, recent advances in using machine learning for the life sciences and medicine are extraordinary. Are we on the verge of a paradigm shift in biotech? This week on the podcast, a pioneer in AI, Daphne Koller, joins Sarah Guo and Elad Gil…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from No Priors: Artificial Intelligence | Technology | Startups
See all episodes →
43%From Restoring Sight to Reimagining the Brain, with Max Hodak
35%Redefining Chip Architecture with Arm CEO Rene Haas
33%Rethinking Legacy Data Infrastructure with Eon Co-Founders Ofir Ehrlich and Gonen Stein
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.